Clinical Trials Directory

Trials / Completed

CompletedNCT01132222

Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions

A Randomized, Open Label, 2-treatment, Single Dose, Crossover, Bioequivalence Study of Ibuprofen 200 mg+Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare Under Fed Conditions.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fed conditions.

Detailed description

This study assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare in healthy human adult subjects with the single oral administration under fed conditions with a washout period of 7 days.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen + Pseudoephedrine HydrochlorideIbuprofen 200 mg + Pseudoephedrine Hydrochloride 30 mg Tablets

Timeline

Start date
2004-09-01
Primary completion
2004-10-01
Completion
2004-10-01
First posted
2010-05-27
Last updated
2010-06-14

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01132222. Inclusion in this directory is not an endorsement.